@graham15
Specifically, our resident researcher/sherlock @pfeifer1982 did a great post on the GvHD differences between CYP and MSB
https://hotcopper.com.au/threads/ann-product-development-program-update-investor-presentation.4267746/page-5?post_id=33968577
"On day 100 -
MSB injected 1.92 billion cells
Cynata injected between 160 mio cells (lower dose - 1/12 of MSB's) and 320 mio cells (higher dose - 1/6 of MSB's)!"
Cymerus for GvHD so far is miles ahead in numbers of cells required and amount of times the patient will need to be dosed.
This WILL lead to a cheaper product that is less invasive for patients.
MSB also bought their GvHD treatment, their only product for sale was developed by another company, Osiris, who they will pay $ to, just like Fuji to CYP.
They have yet to develop their own commercial product from scratch.
2020 - A Year Full Of Potentials, page-223
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.23M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $14.31K | 75.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30232 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 14.43pm 09/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |